Status:
TERMINATED
HIV, Computerized Depression Therapy & Cognition
Lead Sponsor:
McGill University
Conditions:
HIV Infections
Depression
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Among people with HIV, the severity of depressive symptoms has repeatedly been associated with the presence of self-reported cognitive difficulties, even in the absence of impairment on neuropsycholog...
Detailed Description
Among people with HIV, the severity of depressive symptoms has repeatedly been associated with the presence of self-reported cognitive difficulties, even in the absence of impairment on neuropsycholog...
Eligibility Criteria
Inclusion
- Participants in the cohort study "Understanding and Optimizing Brain Health in HIV Now" with at least one remaining visit
- Able to communicate (understand and read) in English
- Depression subscale of the HADS (HADS-D) ≥ 8
- Presence of self-reported cognitive difficulties (PDQ) \>40
- Score on the B-CAM \> 14
- Willing to undergo 9 sessions of cCBT as per instructions and to have weekly contact with a research coordinator from the central site (by email or phone)
- Access to the internet
Exclusion
- • Current use of street drugs (excluding marijuana)
Key Trial Info
Start Date :
September 6 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 13 2019
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT03275571
Start Date
September 6 2017
End Date
August 13 2019
Last Update
September 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McGill University Health Center
Montreal, Quebec, Canada, H4A 3J1